Inadequate Bioavailability of Intramuscular Epinephrine in a Neonatal Asphyxia Model.

asphyxia epinephrine intramuscular low-resource neonatal resuscitation

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 03 12 2021
accepted: 27 01 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

Over half a million newborn deaths are attributed to intrapartum related events annually, the majority of which occur in low resource settings. While progress has been made in reducing the burden of asphyxia, novel approaches may need to be considered to further decrease rates of newborn mortality. Administration of intravenous, intraosseous or endotracheal epinephrine is recommended by the Newborn Resuscitation Program (NRP) with sustained bradycardia at birth. However, delivery by these routes requires both advanced skills and specialized equipment. Intramuscular (IM) epinephrine may represent a simple, low cost and highly accessible alternative for consideration in the care of infants compromised at birth. At present, the bioavailability of IM epinephrine in asphyxia remains unclear. Four term fetal lambs were delivered by cesarean section and asphyxiated by umbilical cord occlusion with resuscitation after 5 min of asystole. IM epinephrine (0.1 mg/kg) was administered intradeltoid after 1 min of positive pressure ventilation with 30 s of chest compressions. Serial blood samples were obtained for determination of plasma epinephrine concentrations by ELISA. Epinephrine concentrations failed to increase following administration Inadequate absorption of epinephrine occurs with IM administration during asphyxial cardiac arrest, implying this route would be ineffective in infants who are severely compromised at birth. Late absorption following ROSC raises concerns for risks of side effects. However, the bioavailability and efficacy of intramuscular epinephrine in less profound asphyxia may warrant further evaluation.

Sections du résumé

Background UNASSIGNED
Over half a million newborn deaths are attributed to intrapartum related events annually, the majority of which occur in low resource settings. While progress has been made in reducing the burden of asphyxia, novel approaches may need to be considered to further decrease rates of newborn mortality. Administration of intravenous, intraosseous or endotracheal epinephrine is recommended by the Newborn Resuscitation Program (NRP) with sustained bradycardia at birth. However, delivery by these routes requires both advanced skills and specialized equipment. Intramuscular (IM) epinephrine may represent a simple, low cost and highly accessible alternative for consideration in the care of infants compromised at birth. At present, the bioavailability of IM epinephrine in asphyxia remains unclear.
Methods UNASSIGNED
Four term fetal lambs were delivered by cesarean section and asphyxiated by umbilical cord occlusion with resuscitation after 5 min of asystole. IM epinephrine (0.1 mg/kg) was administered intradeltoid after 1 min of positive pressure ventilation with 30 s of chest compressions. Serial blood samples were obtained for determination of plasma epinephrine concentrations by ELISA.
Results UNASSIGNED
Epinephrine concentrations failed to increase following administration
Conclusions UNASSIGNED
Inadequate absorption of epinephrine occurs with IM administration during asphyxial cardiac arrest, implying this route would be ineffective in infants who are severely compromised at birth. Late absorption following ROSC raises concerns for risks of side effects. However, the bioavailability and efficacy of intramuscular epinephrine in less profound asphyxia may warrant further evaluation.

Identifiants

pubmed: 35265564
doi: 10.3389/fped.2022.828130
pmc: PMC8899212
doi:

Types de publication

Journal Article

Langues

eng

Pagination

828130

Informations de copyright

Copyright © 2022 Berkelhamer, Vali, Nair, Gugino, Helman, Koenigsknecht, Nielsen and Lakshminrusimha.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer P-YC declared a past collaboration with one of the authors SL to the handling editor BN.

Références

J Perinatol. 2021 Jul;41(7):1769-1773
pubmed: 33712718
Pediatr Res. 2015 Oct;78(4):395-400
pubmed: 26086644
Semin Fetal Neonatal Med. 2008 Dec;13(6):432-9
pubmed: 18495563
Semin Perinatol. 2015 Aug;39(5):326-37
pubmed: 26249104
Arch Dis Child. 2020 Feb;105(2):127-133
pubmed: 31278145
Arch Dis Child Fetal Neonatal Ed. 2011 Nov;96(6):F417-21
pubmed: 21393311
J Appl Physiol (1985). 2011 Nov;111(5):1441-7
pubmed: 21799125
Clin Perinatol. 2006 Mar;33(1):141-51, viii-ix
pubmed: 16533640
Early Hum Dev. 2019 Mar;130:27-32
pubmed: 30660015
Anesth Analg. 2011 Apr;112(4):884-90
pubmed: 21385987
Pediatr Res. 2013 Dec;74 Suppl 1:50-72
pubmed: 24366463
Resuscitation. 2015 May;90:e5
pubmed: 25737081
Am J Emerg Med. 2012 Oct;30(8):1389-94
pubmed: 22205006
Pediatr Crit Care Med. 2017 Aug;18(8):e370-e377
pubmed: 28661972
Ann Emerg Med. 1984 Sep;13(9 Pt 2):840-3
pubmed: 6383142
Resuscitation. 2010 May;81(5):596-602
pubmed: 20176434
PLoS One. 2017 Apr 25;12(4):e0176478
pubmed: 28441439
Pediatrics. 2006 Jan;117(1):e16-21
pubmed: 16396845
Arch Dis Child Fetal Neonatal Ed. 2016 May;101(3):F244-7
pubmed: 26400104
Resuscitation. 2012 Aug;83(8):932-9
pubmed: 22425731
Clin Perinatol. 2012 Dec;39(4):843-55
pubmed: 23164182
Lancet. 2011 Sep 24;378(9797):1139-65
pubmed: 21937100
Arch Dis Child. 1988 May;63(5):570-1
pubmed: 3389882
Children (Basel). 2019 Apr 02;6(4):
pubmed: 30987062
Semin Fetal Neonatal Med. 2013 Dec;18(6):373-8
pubmed: 23896083
J Vis Exp. 2018 Aug 15;(138):
pubmed: 30175999
Lancet. 2014 Jul 12;384(9938):174-88
pubmed: 24853603
Resuscitation. 2012 Jul;83(7):869-73
pubmed: 22198423
Am J Obstet Gynecol. 2007 May;196(5):463.e1-5
pubmed: 17466703
Paediatr Anaesth. 2013 Oct;23(10):906-12
pubmed: 23551871
J Am Heart Assoc. 2017 Feb 18;6(2):
pubmed: 28214793
Curr Opin Crit Care. 2013 Jun;19(3):169-74
pubmed: 23628783

Auteurs

Sara K Berkelhamer (SK)

Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, United States.

Payam Vali (P)

Department of Pediatrics, University California Davis School of Medicine, Sacramento, CA, United States.

Jayasree Nair (J)

Department of Pediatrics, University at Buffalo SUNY, Buffalo, NY, United States.

Sylvia Gugino (S)

Department of Pediatrics, University at Buffalo SUNY, Buffalo, NY, United States.

Justin Helman (J)

Department of Pediatrics, University at Buffalo SUNY, Buffalo, NY, United States.

Carmon Koenigsknecht (C)

Department of Pediatrics, University at Buffalo SUNY, Buffalo, NY, United States.

Lori Nielsen (L)

Department of Pediatrics, University at Buffalo SUNY, Buffalo, NY, United States.

Satyan Lakshminrusimha (S)

Department of Pediatrics, University California Davis School of Medicine, Sacramento, CA, United States.

Classifications MeSH